pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Peptide Therapeutic · news · pharmadog
← back to Peptide Therapeutic
News · Peptide Therapeutic
189
stories
Jul 28, 26
The future of gray-market peptides
endpoints
Jul 28, 26
STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
stat
Jul 28, 26
Anthony Fauci’s pandemic-era diary entries
stat
Jul 27, 26
STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
stat
Jul 27, 26
STAT+: Pharma’s drug spending deflection
stat
Jul 27, 26
Six wellness peptides win backing from FDA advisory committee
endpoints
Jul 27, 26
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
stat
Jul 27, 26
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
stat
Jul 27, 26
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
stat
Jul 27, 26
A trend that isn’t fading, ultra-processed baby foods
stat
Jul 27, 26
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
stat
Jul 27, 26
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
Jul 27, 26
STAT+: Argenx to buy Forte Biosciences for $2.2B
stat
Jul 27, 26
EMA says it takes ultimate responsibility for protecting online meeting registration, survey information
raps
Jul 24, 26
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
stat
Jul 24, 26
STAT+: Fatal gene-editing trial in China raises ethics and oversight questions
stat
Jul 24, 26
STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
stat
Jul 24, 26
A new, separate outbreak of the diarrhea-causing parasite
stat
Jul 24, 26
FDA panel endorses broader use of certain peptides
biopharma dive
Jul 24, 26
FDA advisory committee backs two more peptides, rejects one for compounding list
raps
Jul 23, 26
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
stat
Jul 23, 26
Updated: FDA adcomm backs popular wellness peptides, despite staff concerns
endpoints
Jul 23, 26
U.S. health officials are investigating a new outbreak of a diarrhea-causing parasite
stat
Jul 23, 26
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
Jul 23, 26
STAT+: Popular insulin product enters shortage as other pens leave market
stat
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 23, 26
STAT+: Trump administration quietly picks Timothy Westlake to lead mental health agency
stat
Jul 23, 26
Expect a clash at today’s FDA peptide panel
stat
Jul 23, 26
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
stat
Jul 23, 26
STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
stat
← prev
page 5 of 7
next →